Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0468 Transporter Info | ||||
Gene Name | SLC7A2 | ||||
Transporter Name | Cationic amino acid transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in coronary artery disease condition | [2] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to bind to the transcription of SLC7A2 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Cationic amino acid transporter 2. | |||||
JUNB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [1] | ||||
TF Protein Name |
Transcription factor JunB | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunB (JUNB) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
JUND |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in coronary artery disease condition | [2] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor JunD (JUND) has been reported to bind to the transcription of SLC7A2 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Cationic amino acid transporter 2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC7A2 gene | [3] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Cervix; Colon; Coronary artery; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in melanoma condition | [4] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC7A2 gene in melanoma condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in Coronary artery disease condition | [2] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 21 (TCF21) has been reported to bind to the SLC7A2 gene in Coronary artery disease condition, which affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in breast cancer condition | [5] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Studied Phenotype |
Breast cancer [ICD11: 2C60-2C6Z] | |||||
Tissue |
Breast | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human invasive breast carcinoma of no special type cells (MCF-7) | |||||
Detailed Description |
Estrogen receptor (ESR1) has been reported to activate the transcription of SLC7A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [6] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in breast cancer condition | [7] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of SLC7A2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Cationic amino acid transporter 2. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in gastric cancer condition | [8] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC7A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
GATA6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in gastric cancer condition | [8] | ||||
TF Protein Name |
Transcription factor GATA-6 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-6 (GATA6) has been reported to activate the transcription of SLC7A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [6] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
SALL4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in health condition | [9] | ||||
TF Protein Name |
Sal-like protein 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Sal-like protein 4 (SALL4) has been reported to bind to the transcription of SLC7A2 gene in health condition, which leads to an affected expression of the drug transporter Cationic amino acid transporter 2. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in breast cancer condition | [10] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC7A2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Cationic amino acid transporter 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC7A2 gene in prostate carcinoma condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC7A2 gene in prostate carcinoma condition, which leads to an affected expression of the drug transporter Cationic amino acid transporter 2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
FOXM1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [12] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [3] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in colorectal cancer condition | [13] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC7A2 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in fibrosarcoma condition | [14] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of SLC7A2 gene in fibrosarcoma condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC7A2 gene in hypersensitivity pneumonitis condition | [15] | ||||
TF Protein Name |
Signal transducer and activator of transcription 6 | Transcription Factor Info | ||||
Studied Phenotype |
Hypersensitivity pneumonitis [ICD11: CA70] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
FVB/N mice | |||||
Detailed Description |
Signal transducer and activator of transcription 6 (STAT6) has been reported to activate the transcription of SLC7A2 gene in hypersensitivity pneumonitis condition, which leads to an increased expression of the drug transporter Cationic amino acid transporter 2. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC7A2 gene | [12] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC7A2 gene, which in turn affects the expression or function of the drug transporter Cationic amino acid transporter 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.